152 related articles for article (PubMed ID: 35902132)
1. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
Nguyen TT; Shin DH; Sohoni S; Singh SK; Rivera-Molina Y; Jiang H; Fan X; Gumin J; Lang FF; Alvarez-Breckenridge C; Godoy-Vitorino F; Zhu L; Zheng WJ; Zhai L; Ladomersky E; Lauing KL; Alonso MM; Wainwright DA; Gomez-Manzano C; Fueyo J
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902132
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.
Jiang H; Rivera-Molina Y; Gomez-Manzano C; Clise-Dwyer K; Bover L; Vence LM; Yuan Y; Lang FF; Toniatti C; Hossain MB; Fueyo J
Cancer Res; 2017 Jul; 77(14):3894-3907. PubMed ID: 28566332
[TBL] [Abstract][Full Text] [Related]
3. Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.
Zemp FJ; McKenzie BA; Lun X; Reilly KM; McFadden G; Yong VW; Forsyth PA
Cancer Res; 2014 Dec; 74(24):7260-73. PubMed ID: 25336188
[TBL] [Abstract][Full Text] [Related]
4. A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy.
Awuah SG; Zheng YR; Bruno PM; Hemann MT; Lippard SJ
J Am Chem Soc; 2015 Dec; 137(47):14854-7. PubMed ID: 26561720
[TBL] [Abstract][Full Text] [Related]
5. The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.
Wang Y; Hu GF; Wang ZH
Onco Targets Ther; 2017; 10():3557-3566. PubMed ID: 28790848
[TBL] [Abstract][Full Text] [Related]
6. Photothermal-Enhanced Dual Inhibition of Lactate/Kynurenine Metabolism for Promoting Tumor Immunotherapy.
Xie Y; Wang M; Qiao L; Qian Y; Xu W; Sun Q; Luo S; Li C
Small Methods; 2024 Mar; 8(3):e2300945. PubMed ID: 37906051
[TBL] [Abstract][Full Text] [Related]
7. Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape.
Zhang XY; Shi JB; Jin SF; Wang RJ; Li MY; Zhang ZY; Yang X; Ma HL
Cancer Commun (Lond); 2024 May; ():. PubMed ID: 38734931
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis.
Wirthgen E; Hoeflich A
J Amino Acids; 2015; 2015():973548. PubMed ID: 26881062
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas.
Meléndez-Vázquez NM; Nguyen TT; Fan X; López-Rivas AR; Fueyo J; Gomez-Manzano C; Godoy-Vitorino F
Mol Ther Oncol; 2024 Mar; 32(1):200787. PubMed ID: 38596290
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming the tumor microenvironment leverages CD8
Mistarz A; Winkler M; Battaglia S; Liu S; Hutson A; Rokita H; Gambotto A; Odunsi KO; Singh PK; McGray AJR; Wang J; Kozbor D
Mol Ther Oncolytics; 2023 Mar; 28():230-248. PubMed ID: 36875325
[TBL] [Abstract][Full Text] [Related]
11. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38843203
[TBL] [Abstract][Full Text] [Related]
12. Swine pseudorabies virus attenuated vaccine reprograms the kidney cancer tumor microenvironment and synergizes with PD-1 blockade.
Gui M; Wu C; Qi R; Zeng Y; Huang P; Cao J; Chen T; Chen K; Lin L; Han Q; He P; Fu R; Wu Q; Yuan Q; Zhang T; Xia N; Wang G; Chen Y
J Med Virol; 2024 Apr; 96(4):e29568. PubMed ID: 38549430
[TBL] [Abstract][Full Text] [Related]
13. Uncovering transcriptomic landscape alterations of CAN-2409 in
Koch MS; Zdioruk M; Nowicki MO; Hoetker MS; Herbert ZT; Barone F; Tak PP; Chiocca EA; Tabatabai G; Lawler SE
Front Med (Lausanne); 2023; 10():1140352. PubMed ID: 37228396
[TBL] [Abstract][Full Text] [Related]
14. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
de la Nava D; Ausejo-Mauleon I; Laspidea V; Gonzalez-Huarriz M; Lacalle A; Casares N; Zalacain M; Marrodan L; García-Moure M; Ochoa MC; Tallon-Cobos AC; Hernandez-Osuna R; Marco-Sanz J; Dhandapani L; Hervás-Corpión I; Becher OJ; Nazarian J; Mueller S; Phoenix TN; van der Lugt J; Hernaez M; Guruceaga E; Koschmann C; Venneti S; Allen JE; Dun MD; Fueyo J; Gomez-Manzano C; Gállego Pérez-Larraya J; Patiño-García A; Labiano S; Alonso MM
Neuro Oncol; 2024 Mar; ():. PubMed ID: 38554031
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Modulation of Kynurenine Based on Kynureninase-Loaded Nanoparticle Depot Overcomes Tumor Immune Evasion in Cancer Immunotherapy.
Chae SY; Shin H; Woo J; Kang S; Lee SM; Min DH
ACS Appl Mater Interfaces; 2024 Apr; 16(15):18490-18502. PubMed ID: 38573937
[TBL] [Abstract][Full Text] [Related]
16. Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma.
Ringwalt EM; Currier MA; Glaspell AM; Chen CY; Cannon MV; Cam M; Gross AC; Gust M; Wang PY; Boon L; Biederman LE; Schwarz E; Rajappa P; Lee DA; Mardis ER; Carson WE; Roberts RD; Cripe TP
bioRxiv; 2024 Mar; ():. PubMed ID: 38464161
[TBL] [Abstract][Full Text] [Related]
17. Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry.
Ausejo-Mauleon I; Labiano S; Alonso MM
STAR Protoc; 2024 Mar; 5(1):102803. PubMed ID: 38159270
[TBL] [Abstract][Full Text] [Related]
18. Viroimmunotherapy for Colorectal Cancer: Clinical Studies.
Chaurasiya S; Warner S
Biomedicines; 2017 Mar; 5(1):. PubMed ID: 28536354
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Hydrogel-Mediated Mechano-Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery.
Dong Y; Luo J; Pei M; Liu S; Gao Y; Zhou H; Nueraihemaiti Y; Zhan X; Xie T; Yao X; Guan X; Xu Y
Adv Sci (Weinh); 2024 Jun; ():e2308734. PubMed ID: 38884220
[TBL] [Abstract][Full Text] [Related]
20. OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs.
Yang N; Wang Y; Liu S; Tariq SB; Luna JM; Mazo G; Tan A; Zhang T; Wang J; Yan W; Choi J; Rossi A; Xiang JZ; Rice CM; Merghoub T; Wolchok JD; Deng L
J Exp Med; 2023 Aug; 220(8):. PubMed ID: 37145142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
